Novel Immunocytokine Shows Immune Activation in EGFR+ Solid Tumors
Phase 1 data support further assessment of DK210 (EGFR) in solid tumors such as renal cell carcinoma and non–small cell lung cancer.
Uterine Transposition May Maintain Fertility Following Pelvic Radiotherapy
Uterine transposition, a surgical approach preserving fertility by moving the uterus out of the radiation field, may improve gynecologic cancer outcomes.
FDA Approves Obecabtagene Autoleucel in B-Cell ALL
Results from the FELIX trial support the approval of obecabtagene autoleucel in B-cell ALL.
Empowering Awareness to Address Rising Gynecological Cancer Incidence
Ginger J. Gardner, MD, FACOG, highlights disease prevention innovations and other ongoing efforts to empower education in the gynecologic cancer field.
Dostarlimab Plus Chemo Yield Strong Survival Results in Metastatic NSCLC
Updated OS findings from the PERLA trial showed continued success with dostarlimab plus chemotherapy in patients with advanced non–small cell lung cancer.
FDA, EMA Receive Applications for Subcutaneous Daratumumab in Myeloma
Data from the phase 3 AQUILA study support the applications for subcutaneous daratumumab in high-risk smoldering multiple myeloma.